Recordati Industria Chimica e Farmaceutica S.p.A.
RCDTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,341,559 | $2,082,331 | $1,853,307 | $1,580,074 |
| % Growth | 12.4% | 12.4% | 17.3% | – |
| Cost of Goods Sold | $741,287 | $600,760 | $566,737 | $427,727 |
| Gross Profit | $1,600,272 | $1,481,571 | $1,286,570 | $1,152,347 |
| % Margin | 68.3% | 71.1% | 69.4% | 72.9% |
| R&D Expenses | $286,026 | $255,747 | $220,102 | $166,138 |
| G&A Expenses | $156,648 | $128,253 | $109,493 | $84,495 |
| SG&A Expenses | $654,376 | $601,110 | $572,158 | $480,889 |
| Sales & Mktg Exp. | $497,728 | $472,857 | $462,665 | $396,394 |
| Other Operating Expenses | $21,013 | $66,706 | $497 | -$652 |
| Operating Expenses | $961,415 | $923,563 | $792,260 | $647,027 |
| Operating Income | $638,857 | $558,008 | $437,326 | $490,190 |
| % Margin | 27.3% | 26.8% | 23.6% | 31% |
| Other Income/Exp. Net | -$91,673 | -$66,972 | -$35,891 | -$26,841 |
| Pre-Tax Income | $547,184 | $491,036 | $401,435 | $463,349 |
| Tax Expense | $130,676 | $101,822 | $89,099 | $77,383 |
| Net Income | $416,508 | $389,214 | $312,336 | $385,966 |
| % Margin | 17.8% | 18.7% | 16.9% | 24.4% |
| EPS | 2.02 | 1.86 | 1.52 | 1.87 |
| % Growth | 8.6% | 22.4% | -18.7% | – |
| EPS Diluted | 1.99 | 1.86 | 1.49 | 1.85 |
| Weighted Avg Shares Out | 206,294 | 209,142 | 205,582 | 206,011 |
| Weighted Avg Shares Out Dil | 209,090 | 209,142 | 209,060 | 209,082 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $81,546 | $74,857 | $34,448 | $20,901 |
| Depreciation & Amortization | $167,025 | $142,670 | $125,756 | $97,585 |
| EBITDA | $795,755 | $708,563 | $559,349 | $578,354 |
| % Margin | 34% | 34% | 30.2% | 36.6% |